{"id":328455,"date":"2026-10-27T14:05:02","date_gmt":"2026-10-27T08:35:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/morepen-laboratories-q2-results-fy27-pat-89-crore\/"},"modified":"2026-10-27T14:05:02","modified_gmt":"2026-10-27T08:35:02","slug":"morepen-laboratories-q2-results-fy27-pat-89-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/morepen-laboratories-q2-results-fy27-pat-89-crore\/","title":{"rendered":"Morepen Laboratories Q2 Results FY27: PAT Jumps 116.59% to Rs 88.89 Cr, Revenue Rs 746.50 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Morepen Laboratories Q2 Results FY27 were declared on 27 October 2026, with consolidated revenue of Rs 746.50 Cr, up 81.37% YoY, and net profit of Rs 88.89 Cr, up 116.59% YoY. Operating Profit rose to Rs 123.12 Cr from Rs 30.69 Cr a year earlier. These quarterly results cover July to September 2026 and show YoY growth on all three lines. Univest sets out each figure in the sections below.<\/p>\n<\/div>\n

Morepen Laboratories Ltd<\/a> (MOREPENLAB) Q2 Results FY27 announced on 27 October 2026, covering the company’s financial performance for the July to September quarter. The Morepen Laboratories Q2 Results FY27 filing reports consolidated revenue of Rs 746.50 Cr and net profit of Rs 88.89 Cr. The results date and the consolidated results basis apply to every number in this article, and all comparisons are made with the July to September 2025 quarter.<\/p>\n

This Morepen Laboratories Q2 Results review is a results analysis of the filing, covering the financial highlights, the business factors, the outlook and the risks. Readers can compare the same figures with other companies in the Univest Screener, and the Financial Highlights table comes next.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n